The Introduction of Generic Aromatase Inhibitors and Treatment Adherence Among Medicare D Enrollees

BACKGROUND: Aromatase inhibitors (AIs) substantially reduce breast cancer mortality in clinical trials, but high rates of nonadherence to these long-term oral therapies have reduced their impact outside of trials. We examined the association of generic AI availability with AI adherence among a large...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Natl Cancer Inst
Main Authors: Neuner, Joan M., Kamaraju, Sailaja, Charlson, John A., Wozniak, Erica M., Smith, Elizabeth C., Biggers, Alana, Smallwood, Alicia J., Laud, Purushottam W., Pezzin, Liliana E.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4580559/
https://ncbi.nlm.nih.gov/pubmed/25971298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv130
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares